2009
DOI: 10.1021/op800266x
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of a Corticotropin-Releasing Factor Antagonist by Nucleophilic Aromatic Substitution and Copper-Mediated Ether Formation

Abstract: Several synthetic approaches to a corticotropin-releasing factor (CRF) antagonist containing a tetrasubstituted pyridine were evaluated. In particular, nucleophilic aromatic substitutions on 2,4-dichloropyridine derivatives were attempted using 2,6-dimethyl-4-chlorophenol (4), (S)-2-aminobutanol (7), and several sulfur nucleophiles. It was found that a copper-mediated coupling of a phenoxymesylate (26) was preferred for preparation of the diarylether followed by nucleophilic aromatic substitution to introduce … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
10
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 16 publications
0
10
0
Order By: Relevance
“…The desired product 73 was obtained in only 16% yield after column chromatographic purification. In order to identify the regioselective conditions for the preparation of 73 128 The medicinal route leveraged N-oxide to direct selectivity during the S N Ar coupling of 77 and 78 to afford the desired diaryl ether 80 in 70% yield over the two steps of S N Ar and reduction of the N-oxide intermediate 79. However, process safety evaluation of the N-oxide intermediate 77 revealed an exothermic decomposition event with an onset temperature of 98 °C and total energy release of −806 J/g, which presented potential safety risks for large-scale practice.…”
Section: Applications In Route Design Process Development and Scale-u...mentioning
confidence: 99%
“…The desired product 73 was obtained in only 16% yield after column chromatographic purification. In order to identify the regioselective conditions for the preparation of 73 128 The medicinal route leveraged N-oxide to direct selectivity during the S N Ar coupling of 77 and 78 to afford the desired diaryl ether 80 in 70% yield over the two steps of S N Ar and reduction of the N-oxide intermediate 79. However, process safety evaluation of the N-oxide intermediate 77 revealed an exothermic decomposition event with an onset temperature of 98 °C and total energy release of −806 J/g, which presented potential safety risks for large-scale practice.…”
Section: Applications In Route Design Process Development and Scale-u...mentioning
confidence: 99%
“…O RGANIC reaction including addition reactions [1], elimination reaction [2], substitution reactions [3]- [5], pericyclic reactions [6], rearrangement reactions [7], [8], redox reaction [9] have been studied for hundreds of years. Owing to the development of organic methodology [10], hundreds of millions of reactions have been practiced, and more and more compounds have been produced.…”
Section: Introductionmentioning
confidence: 99%
“…As shown in eq , simply heating chloropyridine 1 with sulfinate 2 in the presence of a catalytic amount TBACl in DMAc at 100 °C for 3 h afforded pyridine 3 in 93% isolated yield . In the absence of TBACl, conversion was <20% at the same time point . We speculated that the significant rate increase in the presence of TBACl could be explained by the formation of n -Bu 4 NSO 2 Tol from TBACl and NaSO 2 Tol. , In order to probe this possibility, we prepared n -Bu 4 NSO 2 Tol and subjected it to the reaction with 1 .…”
mentioning
confidence: 99%